Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

myeloid-derived suppressor cells (MDSCs)

2 abstracts

Abstract
Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma: Preliminary efficacy and mechanism as a monotherapy.
Org: Huashan Hospital Fudan University, Fudan University (Xiamen Branch), Shanghai Henlius Biotech, China National Biotec Group, Zhejiang University, Hangzhou, China,
Abstract
Modulating MDSCs by HF1K16: A mono-therapy phase Ia study examining safety and preliminary efficacy in patients with refractory and metastatic cancer.
Org: Hangzhou Highfield Biopharmaceuticals Inc., Zhejiang University, School of Pharmacy, Hua Shan Hospital, Department of Clinical Pharmacy & Pharmacology, UMCG, Groningen, The First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei, China,